Women's Health

 
Tailoring Weight Management Conversations Across a Woman’s Lifespan
May 27, 2025

Johanna Finkle, MD, outlines how clinicians can adapt weight management counseling during key stages of a woman’s life, from preconception through menopause.

RFK Jr Ends COVID-19 Vaccine Recommendation for Healthy Children, Pregnant Women
May 27, 2025

HHS Secretary Kennedy announced the CDC will no longer recommend vaccination against infection with SARS-CoV-2 for the 2 vulnerable populations.

Combined Oral Contraceptive Use May Triple the Risk of Cryptogenic Stroke in Young Women
May 23, 2025

ESOC 2025: New research reveals that combined oral contraceptive use significantly increases the risk of cryptogenic stroke in young women, urging careful assessment by clinicians.

The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care
May 22, 2025

At ACOG 2025, Elizabeth Mollard, PhD, discussed her research on Medicaid PPD screening and coverage policies on PPD diagnosis.

From Screening to Support: How PCPs Can Tackle PPD
May 21, 2025

ACOG 2025: Joy Baker, MD, urged primary care clinicians to screen early, refer confidently, and help change the statistics on maternal mental health.

Johanna Finkle, MD, on Approaching Weight Loss Discussions with Reproductive-Aged Patients
May 21, 2025

ACOG 2025: Johanna Finkle, MD, shares strategies to start weight conversations with patients and build clinician confidence in counseling and treatment options.

PPD Screening, Medicaid Coverage, and Access to Care: A Q&A with Elizabeth Mollard, PhD
May 20, 2025

ACOG 2025: Elizabeth Mollard, PhD, discusses her research on how Medicaid policies influence postpartum depression screening rates.

“I’m Just Tired”: Listening for the Words Patients Actually Use
May 20, 2025

ACOG 2025: Joy Baker, MD, discusses the importance of listening closely to how patients describe postpartum distress—and to read between the lines.

Laxmi Gannu, MS, Explains a New Study of Clinician's Knowledge of Post Partum Depression
May 19, 2025

ACOG 2025: The Junonia study was designed to understand gaps in care for women with PPD using surveys of their clinicians and care coordinators.

Nanette Santoro, MD, Highlights Findings on Fezolinetant From Pooled Analysis of Phase 3 Skylight Development Program Trials
May 19, 2025

The nonhormonal neurokinin-3 receptor antagonist improved menopausal adiposity without appreciable impact on body weight or BMI, Santoro explained at 2025 ACOG meeting.